Literature DB >> 701458

Immunoglobulin M antibody response against Mycoplasma pneumoniae lipid antigen in patients with acute pancreatitis.

P O Leinikki, P Panzar, H Tykkä.   

Abstract

Serial serum samples from patients with acute pancreatitis showed a significant increase in antibodies against methanol-chloroform-extracted lipid antigen from Mycoplasma pneumoniae when tested by complement fixation. The antibodies did not react with antigens prepared from other human mycoplasmas or from pancreatic tissue by lipid extraction. The antibodies were predominantly immunoglobulin M (IgM). No correlation with cold agglutinins or cardiolipid complement-fixing antibodies was found. The IgM antibody response seemed to be prolonged: after 3 to 4 weeks the antibodies were still in many cases exclusively IgM. Similar IgM responses were also found in certain cases of acute meningoencephalitis. We postulate that during the disease antigenic components identical or very similar to major determinants in the M. pneumoniae lipid antigen are revealed and elicit the IgM antibody response. Their resemblance to natural antibodies and their possible biological role is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 701458      PMCID: PMC275159          DOI: 10.1128/jcm.8.2.113-118.1978

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  AN INDIRECT HEMAGGLUTINATION TEST FOR DIAGNOSIS OF MYCOPLASMA PNEUMONIAE INFECTIONS.

Authors:  W R DOWDLE; R Q ROBINSON
Journal:  Proc Soc Exp Biol Med       Date:  1964 Aug-Sep

2.  EATON PLEUROPNEUMONIA-LIKE ORGANISM (MYCOPLASMA PNEUMONIAE) COMPLEMENT-FIXING ANTIGEN: EXTRACTION WITH ORGANIC SOLVENTS.

Authors:  G E ENNY; J T GRAYSTON
Journal:  J Immunol       Date:  1965-07       Impact factor: 5.422

3.  Antibody response in patients with acute pancreatitis to mycoplasma pneumoniae.

Authors:  P Leinikki; P Pantzar; H Tykkä
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

4.  Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection.

Authors:  D Taylor-Robinson; O Sobĕslavsyý; K E Jensen; L B Senterfit; R M Chanock
Journal:  Am J Epidemiol       Date:  1966-03       Impact factor: 4.897

5.  Immunochemical analysis of Mycoplasma pneumoniae. 3. Separation and chemical identification of serologically active lipids.

Authors:  P Plackett; B P Marmion; E J Shaw; R M Lemcke
Journal:  Aust J Exp Biol Med Sci       Date:  1969-04

6.  Phospholipid hapten of Mycoplasma pneumoniae.

Authors:  B Prescott; G Caldes; W D James; R M Chanock
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

7.  Immunochemical analysis of Mycoplasma pneumoniae.

Authors:  R M Lemcke; B P Marmion; P Plackett
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

8.  Serological and immunogenic activities of different fractions of Mycoplasma pneumoniae.

Authors:  O Sobĕslavský; B Prescott; W D James; R M Chanock
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

9.  Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro.

Authors:  K Penttinen; A Vaheri; G Myllylä
Journal:  Clin Exp Immunol       Date:  1971-03       Impact factor: 4.330

10.  Precipitating antibodies in mycoplasma infection.

Authors:  J Menonna; H Chmel; M Menegus; P Dowling; S Cook
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

View more
  13 in total

1.  A 168-kilodalton protein of Mycoplasma pneumoniae used as antigen in a dot enzyme-linked immunosorbent assay.

Authors:  E Jacobs; K Fuchte; W Bredt
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae.

Authors:  S A Uldum; J S Jensen; J Søndergård-Andersen; K Lind
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

3.  Reaction pattern of human anti-Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting.

Authors:  E Jacobs; A Bennewitz; W Bredt
Journal:  J Clin Microbiol       Date:  1986-03       Impact factor: 5.948

4.  Age-related prevalence of complement-fixing antibody to Mycoplasma pneumoniae during an 8-year period.

Authors:  A Pönkä; P Ukkonen
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

5.  False-positive complement fixing antibodies against Mycoplasma pneumoniae in patients with bacterial meningitis.

Authors:  S M Räisänen; J Suni; A Pönkä; P O Leinikki
Journal:  J Clin Pathol       Date:  1982-08       Impact factor: 3.411

6.  Acute pancreatitis caused by Mycoplasma pneumoniae: an unusual etiology.

Authors:  Teresa Valdés Lacasa; María Alejandra Duarte Borges; Alicia García Marín; Covadonga Gómez Cuervo
Journal:  Clin J Gastroenterol       Date:  2017-03-21

7.  Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections.

Authors:  J Petitjean; A Vabret; S Gouarin; F Freymuth
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

8.  Mycoplasma pneumoniae protein involved in the antibody response in human infection.

Authors:  S Räisänen; J I Suni; A Vaheri
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

9.  Adherence inhibition assay: a specific serological test for detection of antibodies to Mycoplasma pneumoniae.

Authors:  E Jacobs; K Schöpperle; W Bredt
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

10.  Broadly reactive immunofluorescence test for measurement of immunoglobulin M and G antibodies to Ureaplasma urealyticum in infant and adult sera.

Authors:  D Gallo; K W Dupuis; N J Schmidt; G E Kenny
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.